Bio-Techne
TECH
367 hedge funds and large institutions have $6.99B invested in Bio-Techne in 2020 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 134 increasing their positions, 118 reducing their positions, and 47 closing their positions.
400% more funds holding in top 10
Funds holding in top 10: 1 → 5 (+4)
14% more repeat investments, than reductions
Existing positions increased: 134 | Existing positions reduced: 118
8.98% more ownership
Funds ownership: 375.96% → 384.94% (+9%)
2% less funds holding
Funds holding: 375 → 367 (-8)
11% less first-time investments, than exits
New positions opened: 42 | Existing positions closed: 47
11% less capital invested
Capital invested by funds: $7.86B → $6.99B (-$868M)
53% less call options, than puts
Call options by funds: $7.67M | Put options by funds: $16.5M
Top Buyers
| 1 |
OCBV
Ownership Capital B.V.
Amsterdam,
Netherlands
|
+$81.6M |
| 2 |
Select Equity Group
New York
|
+$66.5M |
| 3 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$45.7M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$29.1M |
| 5 |
Citigroup
New York
|
+$26.9M |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$73.5M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$72.1M |
| 3 |
BlackRock
New York
|
-$21.9M |
| 4 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$17M |
| 5 |
FAM
Fred Alger Management
New York
|
-$16.5M |
TECH Hedge Fund Activity: Q1 2020 in Review
367 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q1 2020, worth a combined $6.99B — down 11% from $7.86B a quarter earlier.
Sellers outnumbered buyers: 47 funds closed out of TECH and 42 opened new positions — a net loss of 5 holders — while 118 trimmed existing stakes and 134 added.
The largest buyer was Ownership Capital B.V., opening a new position worth an estimated $81.6M. The largest seller was Janus Henderson Group, cutting an estimated $73.5M.
- 367 institutional investors held Bio-Techne (TECH) as of Q1 2020, down from 375 in Q4 2019.
- Funds reported $6.99B of Bio-Techne stock for Q1 2020, down 11% quarter-over-quarter.
- 42 funds opened new Bio-Techne positions in Q1 2020 and 47 closed out, a net change of -5 holders.
- The largest Bio-Techne buyer in Q1 2020 was Ownership Capital B.V., an estimated $81.6M added.
- The largest Bio-Techne seller in Q1 2020 was Janus Henderson Group, an estimated $73.5M sold.
Based on aggregated 13F filings for Q1 2020.